Neuphoria Therapeutics Inc. (NEUP): Nasdaq/NYSE listing notice — Neuphoria receives Nasdaq deficiency notice for missing annual meeting; plans compliance plan

Neuphoria Therapeutics Inc.

Received Nasdaq notice on July 18, 2025 for failure to hold annual meeting within 12 months of fiscal year ended June 30, 2024.
Must submit compliance plan by September 1, 2025; if accepted, exception until December 29, 2025.
Company plans to hold 2025 annual meeting in November 2025, consistent with past practice.
Deficiency notice has no immediate impact on listing of NEUP common stock.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Neuphoria Therapeutics Inc. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).

Exchange: nasdaq
Notice: deficiency notice
Rules: 5620(a)

Exact text from the filing

July 18, 2025, Neuphoria Therapeutics Inc. (the “Company”) received a deficiency notification letter (the “ Notice ”) from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“ Nasdaq ”). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5620(a) (the “ Listing Rule ”) as a result of the Company’s failure to hold an annual meeting of stockholders within twelve months of the end of the Company’s fiscal year ended June 30, 2024. The Listing Rule requires that a Nasdaq-listed company hold an annual meeting of shareholders no later than one year after

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Neuphoria Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-065723

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.